Mazzilli, Sara
Cocco, Nicola
Petri, Davide
Moazen, Babak
Rosello, Alicia
D’Arcy, Jemima
Plugge, Emma
Baglietto, Laura
Murauer, Eva
Stöver, Heino
Trattonikolas, Tassos
Stylianou, Iakovos
Doltu, Svetlana
Busmachiu, Vladislav
Mavrou, Josefina
Yiasemi, Ioanna
Barbiros, Irina
da Costa, Filipa Alves
Meroueh, Fadi
Ranieri, Roberto
Tavoschi, Lara
Funding for this research was provided by:
Third Health Programme (101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353, 101018353)
Article History
Received: 27 June 2023
Accepted: 10 February 2024
First Online: 10 April 2024
Declarations
:
: The study protocol related to the RISE-Vac project has received approval from the Ethics Committee of the University of Pisa (n. 9/2022 - meeting 25th March 2022, protocol number 0049433/2022 on 12/04/2022). Respondents were recruited among RISE-Vac project consortium partners and allied entities. Verbal informed consent was obtained.
: Not applicable.
: The authors declare no competing interests.
: Filipa Alves da Costa is a consultant for WHO Regional Office for Europe. The author alone is responsible for the views expressed in this publication, and these do not necessarily represent the decisions or the stated policy of the World Health Organization.